Evidence map›Paper›PMID 41710751›Full record

ArticleACS pharmacology & translational science2026

Adenosine-Specific Transcriptional Programs in Murine Connective Tissue-Type Mast Cells.

Qihua Liang, Volodymyr Tsvilovskyy, Anouar Belkacemi, Merima Bukva, Christin Richter, Nicole Ludwig, Andreas Keller, Marc Freichel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qihua LiangInstitute of Pharmacology, Heidelberg University, 69120 Heidelberg, Germany.
Volodymyr TsvilovskyyInstitute of Pharmacology, Heidelberg University, 69120 Heidelberg, Germany.
Anouar BelkacemiInstitute of Pharmacology, Heidelberg University, 69120 Heidelberg, Germany.
Merima BukvaInstitute of Pharmacology, Heidelberg University, 69120 Heidelberg, Germany.
Christin RichterInstitute of Pharmacology, Heidelberg University, 69120 Heidelberg, Germany.
Nicole LudwigClinical Bioinformatics, Saarland University, Saarbrücken 66123, Germany.
Andreas KellerClinical Bioinformatics, Saarland University, Saarbrücken 66123, Germany.
Marc FreichelInstitute of Pharmacology, Heidelberg University, 69120 Heidelberg, Germany.ORCID https://orcid.org/0000-0003-1387-2636

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells are tissue-resident immune cells that are critical for the pathogenesis of allergic and inflammatory disorders. Their physiological functions include host defense against parasites and, more recently, food quality control through antigen avoidance. The purine nucleoside adenosine (ADO), like other mast cell activators, such as antigens or Mrgprb2 agonists, increases intracellular Ca

Indexed as

adenosineantigencalciumcompound 48/80peritoneal mast cellstranscriptome analysis

Identifiers

PMID41710751
PMCPMC12910494

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.